These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 1822408

  • 21. Naftifine cream 1% compared with miconazole cream 2% in dermatophytosis.
    el Darouti MA, Kalinka P.
    Int J Dermatol; 1990 Sep; 29(7):521-2. PubMed ID: 2228386
    [No Abstract] [Full Text] [Related]

  • 22. Allergic contact dermatitis from naftifine in a child without cross-reaction to terbinafine.
    Goday JJ, González-Güemes M, Yanguas I, Ilardia R, Soloeta R.
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):72-3. PubMed ID: 9731972
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Naftifin--laboratory and clinical experience with a new antimycotic from the allylamine group].
    Otcenásek M, Péc J, Moravcík P.
    Cas Lek Cesk; 1993 Jun 28; 132(13):406-9. PubMed ID: 8370053
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Evaluation of the efficacy of a new antimycotic molecule for topical use: naftifine].
    Albanese G, Giorgetti P, Santagostino L, Di Cintio R, Colombo MD.
    G Ital Dermatol Venereol; 1989 May 28; 124(5):XXXIII-XXXVII. PubMed ID: 2620916
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. In vitro and in vivo cutaneous penetration and antifungal activity of naftifine.
    Stoughton RB, Sefton J, Zeleznick L.
    Cutis; 1989 Oct 28; 44(4):333-5. PubMed ID: 2805810
    [Abstract] [Full Text] [Related]

  • 32. Synthesis and structure-activity relationships of naftifine-related allylamine antimycotics.
    Stütz A, Georgopoulos A, Granitzer W, Petranyi G, Berney D.
    J Med Chem; 1986 Jan 28; 29(1):112-25. PubMed ID: 3510297
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Development, optimization and characterization of nanoemulsion loaded with clove oil-naftifine antifungal for the management of tinea.
    Alghaith AF, Alshehri S, Alhakamy NA, Hosny KM.
    Drug Deliv; 2021 Dec 28; 28(1):343-356. PubMed ID: 33517791
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
    Stein Gold LF, Vlahovic T, Verma A, Olayinka B, Fleischer AB.
    J Drugs Dermatol; 2015 Oct 28; 14(10):1138-44. PubMed ID: 26461826
    [Abstract] [Full Text] [Related]

  • 40. Overview of topical therapy for common superficial fungal infections and the role of new topical agents.
    Brennan B, Leyden JJ.
    J Am Acad Dermatol; 1997 Feb 28; 36(2 Pt 1):S3-8. PubMed ID: 9039198
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.